Showing 35,297 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined aidsmap in 2008 and was Managing Editor from 2018 to 2024. As a freelancer, he now edits aidsmap’s news and conference coverage, as well as working on updates to About HIV pages. He is also a contributing science editor for TheBodyPro, a freelance journalist for The Lancet HIV, and a medical writer helping researchers prepare articles for peer-reviewed journals. He began working on HIV at Gay Men Fighting AIDS in the mid-1990s.

PrEP policies & guidelines

HIV-prevention pill now available at Dutch clinics; waiting lists expected

Editor's pick
NL Times
6 August 2019
Injectable & long-acting HIV treatment

DURECT and Gilead Enter into License Agreement for Long-Acting Injectable HIV Investigational Product

Editor's pick
DURECT press release
6 August 2019
People with limited treatment options

Dramatic decline in proportion of people with extensive resistance to anti-HIV medications

News
6 August 2019
Ethnic & cultural minorities

IAS 2019: Data shows indigenous, nonbinary populations among those missed by HIV epidemic ending efforts

Editor's pick
Science Speaks
3 August 2019
The biology of HIV transmission

IAS 2019: Scientist highlights the weight of the smallest organism in HIV risk

Editor's pick
Science Speaks
3 August 2019
Heterosexual men

Men and HIV: how poverty, violence and inequality play a part

Editor's pick
The Conversation
3 August 2019
The search for a cure

Industry $$ for HIV Cure Sparse Due to Unanswered Questions

Editor's pick
MedPage Today
3 August 2019
PrEP science

Does Descovy Really Work Better Than Truvada for PrEP? One Researcher Raises Questions About the DISCOVER Trial Results

Editor's pick
TheBodyPro
3 August 2019
PrEP programmes & uptake

Would You Want a Computer to Judge Your Risk of H.I.V. Infection?

Editor's pick
New York Times
3 August 2019
Resistance

Alarming surge in drug-resistant HIV uncovered

Editor's pick
Nature
3 August 2019
Harm reduction

France Is Testing Safe Drug Consumption Rooms for Opioid Addicts

Editor's pick
Bloomberg
3 August 2019
Global health initiatives

Leading UNAIDS: a once-in-a-generation challenge?

Editor's pick
The Lancet
3 August 2019
Government, leadership & policy

Trump Says We’re Ending AIDS and Curing Childhood Cancer Very Shortly

Editor's pick
POZ
3 August 2019
Hepatitis C treatment

Young adults with vertical HIV and hepatitis C co-infection have a high hepatitis C cure rate

News
2 August 2019
Conference announcements & declarations

Really Rapid Review — IAS 2019 Mexico City

Editor's pick
NEJM Journal Watch
2 August 2019
Women

Daring to dream: the women and girls on HIV's new front line

Editor's pick
The Telegraph
2 August 2019
Epidemiology

HIV-Related Deaths on the Rise in Russia

Editor's pick
The Moscow Times
2 August 2019
Conference announcements & declarations

Reflections from IAS 2019: Policies to End the HIV/AIDS Epidemic

Editor's pick
Friends of the Global Fight
2 August 2019
Changing treatment

High efficacy from switching to bictegravir/F/TAF in virally suppressed participants – including analyses by baseline drug resistance

Editor's pick
i-Base
2 August 2019
The search for a cure

The State of Cure Research for HIV and Hepatitis B: Similarities and Differences

Editor's pick
TheBodyPro
2 August 2019
People with limited treatment options

Clinical and Economic Effects of Ibalizumab for Multidrug-Resistant HIV

Editor's pick
Infectious Disease Advisor
2 August 2019
Cancer

HIV infection worsens cancer outcomes among elderly

Editor's pick
Healio
2 August 2019
Retention & linkage to care

Having Fallen Out of Care, Most Gay and Bisexual Men With Detectable HIV Viral Loads Were Successfully Reconnected, Study Finds

Editor's pick
TheBodyPro
1 August 2019
Hepatitis & HIV

13% of HIV-positive Europeans who are cured of hepatitis C are reinfected

News
31 July 2019